Post by Cyclo Therapeutics, A Rafael Company

We have announced the completion of last patient last visit for Cyclo’s pivotal phase 3 TransportNPC™ study evaluating Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C. https://lnkd.in/eMtWbwiQ